secwatch.observer — SEC 8-K summary
======================================

Issuer:     FILANA THERAPEUTICS, INC. (FLNA)
CIK:        0001069530
Form:       8-K/A
Filed at:   2024-08-09T23:59:59+00:00
Accession:  0001437749-24-025654
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Cassava Sciences corrects diluted EPS for H1 2024 to ($0.28) from ($1.72)
-------------------------------------------------------------------------

- Corrected diluted EPS for six months ended June 30, 2024 is $(0.28), not $(1.72) as originally reported.
- No other financial figures in the August 8, 2024 earnings release are affected by this amendment.
- Corrected figure matches diluted EPS reported in the Form 10-Q filed on August 8, 2024.
- Amendment filed on August 9, 2024; initial 8-K remains unchanged except for the EPS correction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069530/000143774924025654/0001437749-24-025654-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069530/000143774924025654/sava20240809_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-025654

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer